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Trends in influenza vaccination coverage rates in the United
Kingdom over six seasons from 2001-2 to 2006-7
Abstract
In order to understand motivations and barriers to vaccination, and to identify people's intentions to get
vaccinated for season 2007-8, influenza vaccination coverage was assessed in the United Kingdom (UK)
from 2001 to 2007. Between 2001 and 2007 representative household surveys were performed by
telephone interview with 12,143 individuals aged 16 or older. The overall influenza vaccination
coverage rate dropped non-significantly from 25.9% in 2005-6 to 25.0% in 2006-7 (p=0.510). In the
elderly (>/=65 years) the rate decreased from 78.1% to 65.3% (p=0.001), and the odds ratio of being
vaccinated compared to those not belonging to any of the risk groups targeted by vaccination decreased
from 36.6 to 19.9. Healthcare workers and chronically ill persons had odds ratios of 2.0 and 15.5,
respectively. The most important reason for getting vaccinated was a recommendation by the family
doctor or nurse, and this was also perceived as the major encouraging factor for vaccination. No
recommendation from the family doctor was the main reason for not getting vaccinated. A total of
38.4% of the respondents intended to get immunised against influenza in 2007-8. From 2001 to 2006 a
slightly increasing trend (p for trend across seasons <0.0001) in vaccination coverage was observed in
the UK, but in 2006-7 the rates returned to the level of 2004-5. Less media attention to the threat of
avian influenza after 2005 may have contributed to the recent decrease of vaccination rates.
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In order to understand motivations and barriers to vaccination, and 
to identify people’s intentions to get vaccinated for season 2007-8, 
influenza vaccination coverage was assessed in the United Kingdom 
(UK) from 2001 to 2007. Between 2001 and 2007 representative 
household surveys were performed by telephone interview with 
12,143 individuals aged 16 or older. The overall influenza 
vaccination coverage rate dropped non-significantly from 25.9% 
in 2005-6 to 25.0% in 2006-7 (p=0.510). In the elderly (≥65 
years) the rate decreased from 78.1% to 65.3% (p=0.001), and the 
odds ratio of being vaccinated compared to those not belonging to 
any of the risk groups targeted by vaccination decreased from 36.6 
to 19.9. Healthcare workers and chronically ill persons had odds 
ratios of 2.0 and 15.5, respectively. The most important reason 
for getting vaccinated was a recommendation by the family doctor 
or nurse, and this was also perceived as the major encouraging 
factor for vaccination. No recommendation from the family doctor 
was the main reason for not getting vaccinated. A total of 38.4% 
of the respondents intended to get immunised against influenza in 
2007-8. From 2001 to 2006 a slightly increasing trend (p for trend 
across seasons <0.0001) in vaccination coverage was observed in 
the UK, but in 2006-7 the rates returned to the level of 2004-5. 
Less media attention to the threat of avian influenza after 2005 
may have contributed to the recent decrease of vaccination rates.
*OUSPEVDUJPO
Experts at the World Health Organization and elsewhere agree 
that the world is now closer to another influenza pandemic than 
at any time since the 1968 pandemic which was the last of the 
three influenza pandemics that occurred in the twentieth century 
[1]. This underlines the importance of achieving sufficiently high 
immunisation coverage in the general population and above all in 
sub-populations at high risk of influenza complications.
There is ample evidence in the medical literature that vaccination 
is an efficacious and safe preventive measure against seasonal 
influenza [2-4]. It not only provides substantial health benefits, but 
may also be associated with significant economic benefits [5,6], 
particularly among the elderly, healthy working adults and children. 
In the United Kingdom (UK), where complications of influenza 
cause 3,000 to 4,000 deaths every year, the government policy [7] 
is to vaccinate: i) all people aged 65 years and over (age-related 
policy introduced in 2000–1), ii) individuals aged 6 months and 
over who fall into a clinically defined risk group (chronic respiratory 
disease, including asthma, chronic heart disease, chronic renal 
disease, diabetes and immunosuppression), iii) individuals living 
in long-stay, residential-care institutions, iv) health and social-
care professionals involved in direct care. Despite the relatively 
high influenza vaccination coverage of the target groups in UK, 
continuing efforts by physicians, the National Health Service and 
policy makers, are needed to contain the burden of the disease.
Earlier publications based on cross-sectional data have 
reported influenza vaccination rates in the UK [8-10]. However, 
the availability of a consistent dataset for six consecutive seasons 
permits us to expand the usual cross-sectional approach for the 
analysis of vaccination rates.
In this study we analyse influenza vaccination coverage and 
related trends in the UK over six consecutive vaccination seasons, 
with special regard to high-risk group coverage. Further objectives 
are to elucidate the motivations for being or not being vaccinated, 
and to reveal the intentions to get vaccinated for the season 
2007-8.
.FUIPET
The present survey is part of an ongoing international 
assessment of influenza immunisation uptake in five European 
countries, France, Germany, Italy, Spain and UK [11-14]. During 
six influenza seasons, from 2001-2 to 2006-7, a population–based 
telephone survey addressing different topics was carried out in 
December and January among UK households. Computer Assisted 
Telephone Interviews (CATI) were conducted, and the interviewees’ 
consent was obtained at the beginning of each call. There was no 
study intervention. Using quotas and weights based on data from 
official national sources guaranteed that the reported sample of 
the survey (completed interviews) was representative of the non-
institutionalised UK population aged 16 years or older [15]. The 
weighting was applied in terms of sex, age, profession, geographic 
region and town size. 
Four target groups based on national recommendations were 
specified [7]: 
1. Individuals aged 65 years or older
2. Individuals who suffer from a chronic illness
3. Individuals who work in the medical field
4. Individuals belonging to one or more of the above groups 1, 2 
and 3 (composite target group)
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The non-target group comprised individuals belonging to neither 
of groups 1, 2 and 3. The survey questionnaire has been published 
before [15]. The questions covered vaccination uptake, reasons for 
and against vaccination, as well as the intention to get vaccinated 
the next season. In order to assess the gap between actual and 
intended vaccination rates, the ratios between the actual coverage 
level in a given season and the intended level in the same or 
the next season were calculated. Since 2003-4, supplementary 
information on the chronic illness status of the interviewees was 
collected. Data comparing target groups with the non-target group 
were obtained from season 2003-4 to 2006-7. Starting with season 
2005-6, the questionnaire also included questions on pandemic 
and avian influenza. 
Sample weights were applied, and the annual datasets were 
pooled to correct for small deviations from the age and sex 
quotas requested. SPSS® version 14 for Windows was used for 
the statistical evaluation. The chi-square test was used to assess 
bivariate associations of categorical variables and the chi-square 
test for trends was used for assessing time trends of categorical 
variables. For all statistical tests two-sided p≤0.05 was set as the 
level of statistical significance. If available, exact p-values were 
displayed. Ninety-five percent confidence intervals (CI) were reported 
where appropriate. Expected predictor variables were considered 
candidates for multivariate analysis, and logistic regression was 
used to identify independent correlates of the outcome of interest, 
i.e. vaccination coverage. The following variables were regarded 
as potential predictors of vaccination coverage: sex, age, chronic 
illness, working in the medical field, educational level, and income. 
Multivariate logistic regression analysis was used to assess the 
independent explanatory value of these covariates. A full model 
(containing all covariates) was first fitted from the 2006-7 data. 
Non-significant predictors (p > 0.05) were subsequently removed 
on a stepwise basis. The regression models for all other seasons 
were based on the remaining set of influential covariates identified 
from the 2006-7 dataset. Due to the descriptive nature of this data, 
no correction for multiple testing was made.
3FTVMUT 
Response rate
In the 2006-7 coverage study 2,037 individuals completed 
the interview (6.0% of responses). A total of 12,143 persons were 
interviewed since 2001. An overview of the samples is shown in 
Table 1. The samples were composed similarly over the years and 
are representative of the population aged 16 or older [15,16]. 
Vaccination coverage rate
Figure 1 shows the actual as well as the intended influenza 
vaccination rates over time. Overall vaccination coverage rates 
declined non-significantly from 25.9% (95%CI: 23.9;27.9) 
in season 2005-6 to 25.0% (95%CI: 23.0;27.0) in season 
2006-7 (p=0.510). With regard to the coming season of 2007-8, 
38.4% (95% CI: 36.8-40.1) of the interviewees intended to get 
immunised against influenza (Figure 1). The ratio of actual and 
intended vaccination rates ranged between 0.58 and 0.69 over 
the years. Throughout, the intention to get vaccinated was much 
higher than the actual rate in the current or in the previous season 
(Figure 1). 
In 2006-7, the proportion of vaccinated persons who had also 
been vaccinated in the past (22.4%) was very similar as in the 
previous season (22.6%), but significantly higher than in the seasons 
before 2005-6 (19.8% to 20.4%). At the same time, the proportion 
of individuals who had been vaccinated in the past, but not in the 
current season, decreased from 17.6% in 2005-6 to 16.9% in 
2006-7 (not statistically significant), possibly a fluctuation of an 
increasing vaccination trend since season 2001-2. In 2006-7, the 
proportion of respondents who were vaccinated for the first time 
Ta b l e  1
Overview of samples included in the in&uenza vaccination coverage surveys, United Kingdom, from 2001-2 to 2006-7 (n = 12,143)
2001-2 2002-3 2003-4 2004-5 2005-6 2006-7
Total sample size (N) 2,023 2,028 2,026 2,005 2,024 2,037
Mean age ( years) 44.5 45 44.9 45.2 44.8 45
(95% CI) (43.7- 45.4) (44.2- 45.8) (44.1- 45.7) (44.4- 46.0) (44.0- 45.6) (44.1- 45.8)
Male 48.8% 48.8% 48.9% 48.8% 48.9% 48.6%
(95% CI) (48.3%- 49.1%) (48.3%- 49.1%) (48.4%- 49.4%) (48.3%- 49.1%) (48.4%- 49.4%) (46.7%- 50.5%)
N 987 989 991 978 990 990
Age ≥ 65 years 18.1% 18.7% 19.2% 18.7% 19.0% 18.9%
(95% CI) (17.9%- 18.3%) (18.5%- 18.9%) (19.0%- 19.4%) (18.5%- 18.9%) (18.8%- 18.9%) (18.7%- 19.1%)
N 366 380 389 375 384 384
Work in the medical field 6.8% 8.2% 7.1% 6.8% 6.6% 6.4%
(95% CI) (4.9%- 8.7%) (6.3%- 10.1%) (5.2%- 9.0%) (4.9%- 8.7%) (4.7%- 8.5%) (4.5%- 8.3%)
N 138 167 144 136 133 130
Chronic illness - - 12.0% 14.0% 14.2% 14.4%
(95% CI) (10.1%- 13.9%) (12.1%- 15.9%) (12.3%- 16.1%) (12.6%- 16.3%)
N 243 281 288 294
Combined target group* - - 33.0% 33.2% 33.1% 33.2%
(95% CI) (31.0%- 35.1%) (31.1%- 35.2%) (31.1%- 35.2%) (31.1%- 35.2%)
N   669 665 671 676
*Includes people aged 65 years and over, suffering from chronic illnesses or working in medical field
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(2.6%) was one fifth lower than in the preceding season (3.3%), 
whereas the proportion of those who had never been vaccinated 
increased from 57.1% to 58.1%. In spite of this small increase, 
there is no statistical evidence for a reversal of the decreasing trend 
in the long-term (p for trend across seasons <0.0001).
Vaccination coverage in target groups
For the target groups, changes in vaccination coverage over 
time are shown in Figure 2. In the group aged 65 years or older, 
coverage peaked in season 2005-6 at 78.1% (CI: 73.1%;83.1%), 
and then returned to 65.3% (95% CI: 60.3-71.3) in 2006-7 
(p=0.001). Statistical significance in this case indicates that 
there may be a long-term upwards trend despite a substantial 
degree of yearly variation. In every season, coverage in this group 
was at a significantly higher level than in the non-target group 
(p<0.0001). 
Age-related differences in vaccination coverage over time were 
shown in Figure 3. Being elderly (≥65 years) was associated with 
the highest coverage (Figure 3). The lowest values were seen in 
the 16-39 years old. 
A question exploring the prevalence of chronic illness was 
included in the questionnaire from season 2003-4 onwards. 
Over the four observed seasons, significantly higher vaccination 
rates were found among the chronically ill, compared to the non-
target group. In season 2006-7, an increase to 59.4% (95% CI: 
52.4-67.4) was seen in this group, contrasting with values of 47.2% 
(95% CI: 39.2-55.2) in 2003-4 and 47.5 (95% CI: 39.5-54.5) in 
season 2005-6. Vaccination coverage in the group of healthcare 
professionals tended to decline over the years (p for trend = 0.152) 
but after the lowest value of 14.3 (95% CI: 7.3-20.3) in season 
2005-6 rose to 15.9% (95% CI: 8.9-22.9) in season 2006-7. Even 
though the coverage in this group is the lowest among target groups, 
it still is about twice as high as in the non-target group (8.6%; 95% 
CI: 6.6-9.6). In the composite target group, vaccination coverage 
was essentially stable in the period from 2003-4 to 2006-7, with 
three seasons in the range from 57.3% to 57.9% and a peak of 
60.4% (95% CI: 57.4-64.4) in season 2005-6.
Factors influencing vaccination coverage
Multivariate analysis of immunisation coverage accounted for 
membership in one or several target groups covering age, sex, 
educational level, and income. Since target group membership 
was the only covariate that showed a statistically significant effect 
in season 2006-7, the other potential influences (some of which 
suffered from considerable numbers of missing values) were 
excluded from the final logistic regression models (Table 2). A sex 
difference was apparent over time, with men being moderately 
less likely than women to be vaccinated (unadjusted odds ratio for 
women in season 2006-7: 1.2; CI 1.0; 1.5; p=0.062). However, no 
sex difference was present after adjusting for age, chronic illness, 
healthcare work and income. In 2006-7, the percentage of men in 
F i g u r e  1
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the non-target group was 52%, in the elderly it was 39.6%, in the 
chronically ill 48.5% and in the healthcare workers 30.8%.
Age 65 years or older was a significant predictor of vaccination 
(adjusted OR in 2006-7, compared to the non-target group: 19.9; 
odds ratios (ORs) ranging from 16.8 in season 2004-5 to 36.6 in 
season 2005-6). Individuals in the chronically ill target group had 
an odds ratio of 15.5 in season 2006-7, which was higher than in 
the previous three seasons (OR ranging from 9.3 to 11.2). Being 
aged 65 years or older and chronically ill raised the prediction of 
getting vaccinated distinctively in all seasons, with a maximum of 
76.4 in season 2004-5. The likelihood of vaccination of health-
care professionals was in the range of 1.8 and 3.8, and was 2.0 
in season 2006-7.
The probability of vaccination for the composite target group 
(at least one of age ≥65 years, chronic illness, health-care worker) 
was 14.6 (CI: 11.5; 18.7) in season 2006-7, which was equal to 
the average of the four seasons from 2003-4 (data not shown). 
The highest probability of getting vaccinated was seen in season 
2005-6 (OR 15.8; CI: 12.4; 20.1), and there was no trend over the 
four seasons covered (p for trend = 0.658, data not shown).
Motivations and barriers to vaccination
Table 3 shows reasons for getting or not getting vaccinated and 
how frequently they were named. In all seasons between 2001-2 
and 2006-7 the reasons most frequently stated by those who had 
been vaccinated were “My family doctor/nurse advised me to do 
it” and “Because the flu is a serious illness and I did not want 
to get it”. The media coverage of avian influenza and influenza 
pandemics had influenced the decision of 6.7% of the vaccinated 
respondents in 2006-7. This subgroup was not statistically different 
from the other vaccinated in terms of age, sex and belonging to a 
target group. 
In season 2006-7 the most common reason for having never 
been vaccinated was “My family doctor did not recommend it to 
me” (38%, Table 3). Individuals previously vaccinated, but not in 
the current season (2006-7), most frequently said “I didn’t think 
about it, I forgot it” (27.8%, previous season 28.1%), followed by 
“I do not feel concerned” (23.8%, same as in previous season).
There was little change in the knowledge about influenza 
vaccination in season 2006-7 compared to the previous seasons. 
Three-quarters of the surveyed were aware that it is possible to 
catch influenza even if vaccinated, and about two-thirds knew that 
Ta b l e  2
Adjusted odds ratios of vaccination coverage in target groups vs. the non-target group (adjusted for age ≥ 65 years, chronic illness, working 
in the medical .eld); in&uenza vaccination coverage surveys, United Kingdom, from 2003-4 to 2006-7 (n = 8,048)
Target group 2003-4n=2,013*
2004-5
n=1,994*
2005-6
n=2,015*
2006-7
n=2,026*
Age ≥ 65 years
OR 25.9 16.8 36.6 19.9
(95% CI) (18.8; 35.6) (12.3; 23.0) (25.9; 51.7) (14.6; 27.3)
p-value <0.001 <0.001 <0.001 <0.001
N 266 282 248 258
Chronic illness
OR 10.0 11.2 9.3 15.5
(95% CI) (6.8; 14.6) (7.8; 16.1) (6.5; 13.4) (10.8; 22.2)
p-value <0.001 <0.001 <0.001 <0.001
N 144 169 179 186
Chronic illness and age ≥ 65 years
OR 42.8 76.4 46.2 51.9
(95% CI) (24.3; 75.3) (40.3; 144.7) (27.1; 78.5) (30.1; 89.6)
p-value <0.001 <0.001 <0.001 <0.001
N 83 103 105 119
Work in medical field
OR 3.8 2.4 1.8 2.0
(95% CI) (2.4; 6.0) (1.5; 3.9) (1.0; 3.1) (1.1; 3.4)
p-value <0.001 <0.001 0.055 0.017
N 134 123 117 118
Work in medical field or chronic illness or age ≥ 65 years
OR 18.0 13.0 12.6 3.9
(95% CI) (17.1; 45.4) (4.4; 38.6) (5.5; 28.8) (1.4; 10.9)
p-value <0.001 <0.001 <0.001 0.01
N 20 14 24 17
* n< total sample for the season due to missing covariate values
Reference category: non-target group (persons who do not belong to any target group)
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the infection is then less severe. A third of the interviewed persons 
agreed with the statement that the influenza vaccine would protect 
them against avian influenza, whereas a weak majority disagreed 
(52.5%). 
The survey also showed that most people would be encouraged 
to get vaccinated in the future:
• “If my family doctor/nurse recommended it to me” (rank 1, 
72%),
• “If I had more information on the vaccine regarding efficacy 
and/ or tolerance” (rank 2, 46%),
• “If my pharmacist recommended it to me” (rank 3, 35%),
• “If I knew more about the disease” (rank 4, 37%),
• “If there were other ways of administering the vaccine (orally, 
injection without needle)” (rank 5, 34%).
%JTDVTTJPOBOEDPODMVTJPO
Telephone interviews have been used on a number of occasions 
to study vaccination coverage in the UK [9]. The random drawing 
of telephone numbers has been shown to be a good basis for a high 
quality selection process [17].
Despite correct sampling non-response is the major potential 
reason for selection bias. Comparisons of telephone, mail and face-
to–face surveys on health-related issues, however, revealed only 
minor differences between modes of administration and modest 
non-response effects with respect to prevalence estimates [16,18]. 
In comparison with mailed surveys, non-response was found to be 
less content-oriented in telephone surveys [19]. Furthermore, bias 
due to dissimilar sociodemographic characteristics of individuals not 
reachable by telephone only slightly affected reporting of illness and 
related use of medical services, as long as the general population 
was addressed, and telephone coverage exceeded 90% [19,20]. 
These reports support the validity of our approach, even though 
we had no ways to independently confirm self-reported vaccination 
status. An earlier publication has described the limitations of the 
present data collection in greater detail [15]. The use of wireless 
telephones is a growing problem. In the United States (US) persons 
with landlines were shown to have higher odds of being vaccinated 
than those with exclusive access to wireless telephones (OR 1.27) 
[21]. If the same is true in the UK where mobile phones are even 
more common than in the US [22-24], our reported vaccination 
rates may have been slightly over-estimated.
The decrease in overall vaccination coverage in the UK in 
season 2006-7, compared to seasons 2004-5 and 2005-6, was 
not statistically significant. Coverage was still higher than in the 
seasons before 2004-5 and there is no strong evidence for a 
long-term change of trend. In 2006-7, 38.4% of the respondents 
expressed the intention to get vaccinated in season 2007-8. Thus, 
in the UK there may be a potential to increase future vaccination 
coverage provided that those who intend to get vaccinated but in 
the end do not are better targeted. Additionally, the increasing 
trend of those who had been vaccinated in the past but not in the 
current season could be explained by a failure of vaccine campaigns 
to maintain their trust in vaccination. A decreasing trend, however, 
was apparent in the age group of 65 to 69 years old respondents 
whose coverage dropped to the lowest level since season 2001-2 
(Figure 3). As vaccinations are offered free of charge by the UK 
National Health Service, and as it is government policy to vaccinate 
all people aged 65 years and older we have no explanation for 
the decreasing trend in this particular age group. No trend over 
all seasons was apparent in the age group of 70 years or older, 
although the vaccination coverage in this group also reached the 
peak level in season 2005-6 and in 2006-7 returned to similar 
value as in season 2004-5. 
In the two years before season 2006-7, the UK media have 
frequently reported on avian influenza and a potential shortage 
of antiviral agents. This may have increased the primary care 
providers’ awareness of the risk of influenza pandemic and, by 
consequence, may have positively affected vaccination coverage in 
one of the high risk groups, namely the elderly, in season 2005-6. 
However, after season 2005-6 avian influenza lost the focus of 
the media [25], which may be a possible cause of the coincident 
decline in vaccination rates in 2006-7 to levels observed before 
the 2005-6 season. However, only less than 7% of respondents 
Ta b l e  3
Ranking of reasons for and against vaccination; in&uenza vaccination coverage surveys, United Kingdom, from 2001-2 to 2006-7 (n = 10,252)
Motivations to get vaccinated 
(among those vaccinated in the current season)
2001-2
n=458
Rank (%)
2002-3
n=451
Rank (%)
2003-4
n=497
Rank (%)
2004-5
n=507
Rank (%)
2005-6
n=524
Rank (%)
2006-7
n=509
Rank (%)
My family doctor/nurse advised me to do it 2 (70) 2 (75) 1 (49) 1 (60) 1 (51) 1 (60)
Because flu is a serious illness and I did not want to get it 1 (73) 1 (82) 2 (47) 2 (46) 2 (42) 2 (50)
Because of my age 3 (59) 4 (56) 3 (41) 3 (39) 3 (40) 3 (42)
Because I am not in a very good health 6 (34) 6 (33) 5 (25) 4 (30) 5 (25) 4 (32)
So I do not pass the flu bug to my family and friends 4 (56) 3 (57) 4 (28) 5 (28) 4 (27) 5 (32)
Because the social security system pays for it 5 (40) 5 (36) 6 (25) 6 (26) 6 (24) 6 (29)
Reasons for not getting vaccinated
(among those never vaccinated)
2001-2
n=1,281
Rank (%)
2002-3
n=1,274
Rank (%)
2003-4
n=1,228
Rank (%)
2004-5
n=1,185
Rank (%)
2005-6
n=1,155
Rank (%)
2006-7
n=1,183
Rank (%)
My family doctor did not recommend it to me 1 (56) 1 (54) 2 (33) 1 (37) 2 (37) 1 (38)
I have never considered it before 2 (56) 2 (51) 3 (33) 2 (34) 1 (37) 2 (35)
I do not think I am very likely to catch the flu 4 (32) 3 (41) 1 (34) 3 (33) 3 (30) 3 (33)
I am too young to be vaccinated 3 (34) 4 (37) 4 (29) 4 (31) 4 (29) 4 (32)
My pharmacist did not recommend it to me - 5 (34) 5 (17) 5 (18) 5 (19) 5 (21)
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listed the media as one of the factors influencing the decision to 
get vaccinated. Also, it neither explains the transitory decline in 
vaccination coverage in the chronically ill group in season 2005-6, 
nor the more long-term decrease in the healthcare professionals’ 
vaccination rates. Working as health professional in the UK did not 
distinctly encourage vaccination as the adjusted odds were several 
magnitudes lower than those of the other defined target groups. 
Furthermore, the rate of vaccinated healthcare workers seemed 
to be decreasing (although statistically non-significant). Previous 
publications on influenza vaccination coverage [26-31] found low 
coverage rates in healthcare workers in Germany, ranging from 8% 
to 26% [27]. In comparison, in the UK surveys from 2001-2 to 
2006-7 we obtained vaccination coverage in healthcare workers 
ranging between 14.3% and 25.2%, whereas the rates in non-
target group never exceeded 9.4%.
Our observations on immunisation uptake in the UK population 
are largely consistent with findings from studies performed in the 
UK using a representative general practice database [32]. One 
notable difference regarding coverage trends is that in contrast with 
our findings the study by Coupland et al. found invariably increasing 
vaccination rates from every season to the next in all risk groups. The 
reason for these divergent results may primarily lie in the different 
approaches to collecting data; while Coupland’s data were sampled 
from a subset of the population that visited a general practitioner 
(QRESEARCH database [33,34]), our data were sampled from the 
entire population accessible by telephone, irrespective of whether 
the respondents visited a physician or not. 
Vaccination rates of children and young people under 16 years 
of age were not covered by our article. However, high vaccination 
coverage in children will be difficult to achieve at least in some 
countries, as paediatric recommendations for influenza vaccination 
in healthy children in most countries are nonexistent. This is why 
reaching high vaccination levels in the risk populations is even 
more important. 
The overall vaccination rate in eleven European countries was 
20.2% in season 2006-7 [our survey series, unpublished data]. 
Thus, in season 2006-7 the vaccination rate in the UK (25.0%) 
was higher than the European average. In previous seasons, the 
UK rates were above or slightly below the average of five European 
countries [13,19,35]. 
Regarding individual motivations for vaccination, our data 
confirm that the recommendation from the family doctor or nurse 
is the most important encouraging factor. Other publications 
support this finding [15,26,31,36-38]. A better understanding of 
the disease and administration of the vaccine without needle would 
generally encourage a third of the surveyed, and more information 
on the vaccine would encourage two-fifths of the respondents to 
get vaccinated in the future.
In order to achieve higher vaccination coverage, dealing with 
barriers to vaccination and enhancing positive motivations remain 
an important undertaking in the UK. This challenge should be 
accepted not only by the patients’ key motivators, the primary care 
professionals, but also by government agencies, health professional 
organisations and independent media, which could all contribute 
to bridging the knowledge gap.
According to the WHO, the influenza pandemic risk remains on a 
high level [1]. Efforts should be made at national and international 
levels to raise coverage as set out in the WHO objectives (i.e. 50% 
vaccination coverage in the elderly to be reached in 2006 and 
75% in 2010 [39]). As in the years before, the UK exceeded the 
2006 goal with the 2006-7 vaccination rate reaching 65.3% in 
those aged 65 years and older. To arrive at the WHO objectives for 
2010, though, additional efforts are required, and this remains a 
challenge for health organisations, primary healthcare providers, 
government, and the media.
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